scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0008-6363(03)00516-9 |
P953 | full work available at URL | http://academic.oup.com/cardiovascres/article-pdf/59/4/812/7522413/59-4-812.pdf |
https://academic.oup.com/cardiovascres/article-pdf/59/4/812/7522413/59-4-812.pdf | ||
P698 | PubMed publication ID | 14553821 |
P2093 | author name string | Charles B. Jones | |
David C. Sane | |||
David M. Herrington | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | physiology | Q521 |
acute coronary syndrome | Q266018 | ||
Cardiology and cardiovascular medicine | Q96320350 | ||
P304 | page(s) | 812-823 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome | |
Matrix metalloproteinases A review of their structure and role in acute coronary syndrome | |||
P478 | volume | 59 |
Q44980046 | 8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells |
Q38145567 | A platelet-inspired paradigm for nanomedicine targeted to multiple diseases |
Q35072984 | A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA" |
Q37765287 | A timely diagnosis of myocardial infarction. |
Q87418481 | Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability |
Q35205043 | Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis |
Q35709244 | Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis |
Q28283856 | Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population |
Q37578262 | Beta-adrenoceptor Activation by Norepinephrine Enhances Lipopolysaccharide-induced Matrix Metalloproteinase-9 Expression Through the ERK/JNK-c-Fos Pathway in Human THP-1 Cells |
Q23918414 | Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 decline |
Q36114066 | Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. |
Q33797629 | Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function |
Q36760539 | COX-2 and the vasculature: angel or evil? |
Q37105193 | Cardiovascular inflammation |
Q46734616 | Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. |
Q46878280 | Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. |
Q45166020 | Decreased expression of matrix metalloproteinase-9 and increased expression of tissue inhibitors of matrix metalloproteinase-1 in paratuberculosis-infected cattle in the ELISA-negative subclinical stage |
Q36403328 | Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling |
Q37681570 | Development of an aptamer-conjugated fluorescent nanoprobe for MMP2. |
Q23921517 | Early elevation of serum MMP-3 and MMP-12 predicts protection from World Trade Center-lung injury in New York City firefighters: a nested case-control study |
Q39277240 | Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells |
Q46911133 | Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients |
Q30409097 | Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery. |
Q36095176 | Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis |
Q53062247 | Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis. |
Q89617856 | Feeling Things Out: Bidirectional Signaling of the Cell-ECM Interface, Implications in the Mechanobiology of Cell Spreading, Migration, Proliferation, and Differentiation |
Q34731498 | Genetic effects on postprandial variations of inflammatory markers in healthy individuals |
Q34623513 | Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity. |
Q87881232 | Genetic variants of the matrix metalloproteinase family genes and risk for hypertension: a case-control study among northeastern Han Chinese |
Q33572465 | Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels |
Q42053870 | High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity |
Q34437265 | High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome |
Q35803849 | Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells |
Q44810471 | Identifying the regulative role of NF-κB binding sites within promoter region of human matrix metalloproteinase 9 (mmp-9) by TNF-α induction |
Q42972140 | Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques. |
Q53589745 | Immunohistochemical analysis on MMP-2 and MMP-9 for wound age determination. |
Q48228211 | Increased Levels of Soluble Cluster of Differentiation 40 Ligand, Matrix Metalloproteinase 9, and Matrix Metalloproteinase 2 Are Associated with Carotid Plaque Vulnerability in Patients with Ischemic Cerebrovascular Disease |
Q64092518 | Integrative Analysis Revealing Human Adipose-Specific Genes and Consolidating Obesity Loci |
Q37456901 | Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stress |
Q36302470 | Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome |
Q28395449 | MMP-2 and TIMP-1 predict healing of WTC-lung injury in New York City firefighters |
Q33820443 | MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study |
Q35529307 | MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK. |
Q50916304 | Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. |
Q47223491 | Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease |
Q36542806 | Matrix metalloproteases and PAR1 activation |
Q39414242 | Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α. |
Q35107715 | Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo |
Q42988559 | Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. |
Q36009930 | Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease |
Q37380847 | Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. |
Q38014069 | Matrix metalloproteinases |
Q37224482 | Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. |
Q36081593 | Matrix metalloproteinases and diabetic vascular complications. |
Q46060562 | Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction |
Q37559372 | Matrix metalloproteinases and peripheral arterial disease |
Q36477722 | Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease |
Q35733486 | Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives |
Q38024303 | Matrix metalloproteinases: a review of their structure and role in systemic sclerosis |
Q36752100 | Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability |
Q35750269 | Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties |
Q51475687 | Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes. |
Q51128003 | Molecular dynamics simulation study on the interaction of collagen-like peptides with gelatinase-A (MMP-2). |
Q37557366 | Molecular imaging in cardiovascular disease: targets and opportunities |
Q38648056 | Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease |
Q39138216 | New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. |
Q51730474 | New methods to image unstable atherosclerotic plaques. |
Q26861815 | Novel mechanistic and clinical implications concerning the safety of statin discontinuation |
Q47099030 | Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells |
Q35103192 | Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits |
Q46863979 | Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism |
Q36634707 | Polymorphisms in matrix metalloproteinases MMP1 and MMP9 are associated with primary open-angle and angle closure glaucoma in a Pakistani population. |
Q54968783 | Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein. |
Q35048514 | Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. |
Q38850914 | Prospects for the therapeutic application of sulfated polysaccharides of brown algae in diseases of the cardiovascular system: review |
Q53668219 | Proteomic profiling of acute coronary thrombosis reveals a local decrease in pigment epithelium-derived factor in acute myocardial infarction. |
Q55041980 | Pterostilbene Inhibits Vascular Smooth Muscle Cells Migration and Matrix Metalloproteinase-2 through Modulation of MAPK Pathway. |
Q30577193 | Radiolabelled probes for imaging of atherosclerotic plaques. |
Q36140890 | Recent findings on the role of gelatinases (matrix metalloproteinase-2 and -9) in osteoarthritis |
Q36882229 | Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells |
Q34702697 | Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2. |
Q36567357 | Role of matrix metalloproteinase-8 in atherosclerosis |
Q51835885 | Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. |
Q51097392 | Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome. |
Q42423089 | Squaric acid-based peptidic inhibitors of matrix metalloprotease-1. |
Q37639014 | TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model |
Q36304170 | Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging |
Q45190630 | Temporal expression of metalloproteinase-8 and -13 and their relationships with extracellular matrix metalloproteinase inducer in the development of ligature-induced periodontitis in rats |
Q55471070 | The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events. |
Q51770077 | The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activator. |
Q36831073 | The downstream regulation of chemokine receptor signalling: implications for atherosclerosis |
Q43873018 | The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial |
Q46790428 | The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding. |
Q35013868 | The pathophysiology of obesity and its clinical manifestations |
Q38273202 | The significance of matrix metalloproteinases in parasitic infections involving the central nervous system |
Q35744631 | The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach |
Q43296924 | Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction |
Q37413679 | Type I interferon modulates monocyte recruitment and maturation in chronic inflammation |
Q38068594 | Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology |
Q36422755 | Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy |
Q37088243 | Vascular actions of estrogens: functional implications |
Q36271838 | Venous hypertension and the inflammatory cascade: major manifestations and trigger mechanisms |
Search more.